APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angiotensin Converting Enzyme (ACE) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Angiotensin Converting Enzyme (ACE) Inhibitors Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchAngiotensin Converting Enzyme (ACE) Inhibitors Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiotensin Converting Enzyme (ACE) Inhibitors Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Angiotensin Converting Enzyme (ACE) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiotensin Converting Enzyme (ACE) Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Angiotensin Converting Enzyme (ACE) Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Angiotensin Converting Enzyme (ACE) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Angiotensin Converting Enzyme (ACE) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiotensin Converting Enzyme (ACE) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Angiotensin Converting Enzyme (ACE) Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Angiotensin Converting Enzyme (ACE) Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Angiotensin Converting Enzyme (ACE) Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Angiotensin Converting Enzyme (ACE) Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Angiotensin Converting Enzyme (ACE) Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Angiotensin Converting Enzyme (ACE) Inhibitors Market by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

Abbott Laboratories

Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type

Dicarboxylate-containing Agents

Sulfhydryl-containing Agents

Phosphonate-containing Agents

Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Application

Cardiovascular Diseases

Kidney Diseases

Hypertension

Other

Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin Converting Enzyme (ACE) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin Converting Enzyme (ACE) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin Converting Enzyme (ACE) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Angiotensin Converting Enzyme (ACE) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Angiotensin Converting Enzyme (ACE) Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dicarboxylate-containing Agents Table 2. Major Company of Sulfhydryl-containing Agents Table 3. Major Company of Phosphonate-containing Agents Table 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (k tons) Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 7. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2021-2026) Table 9. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2021-2026) & (US$/ton) Table 10. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2027-2032) & (k tons) Table 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2027-2032) Table 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2027-2032) & (US$/ton) Table 15. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (k tons) Table 16. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (k tons) Table 18. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (k tons) Table 20. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (k tons) Table 22. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (k tons) Table 24. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 25. Angiotensin Converting Enzyme (ACE) Inhibitors Industry Trends Table 26. Angiotensin Converting Enzyme (ACE) Inhibitors Industry Drivers Table 27. Angiotensin Converting Enzyme (ACE) Inhibitors Industry Opportunities and Challenges Table 28. Angiotensin Converting Enzyme (ACE) Inhibitors Industry Restraints Table 29. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Market Share by Company (2021-2026) Table 31. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Company (2021-2026) & (k tons) Table 32. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Company (2021-2026) Table 33. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Price by Company (2021-2026) & (US$/ton) Table 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Angiotensin Converting Enzyme (ACE) Inhibitors Major Company Production Sites and Headquarters Table 36. Global Angiotensin Converting Enzyme (ACE) Inhibitors Company, Product Type & Application Table 37. Global Angiotensin Converting Enzyme (ACE) Inhibitors Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Angiotensin Converting Enzyme (ACE) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2021-2026) & (k tons) Table 42. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 43. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 44. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Region (2021-2026) Table 45. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2027-2032) & (k tons) Table 47. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 48. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 49. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Region (2027-2032) Table 50. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 51. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (k tons) Table 53. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 54. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 55. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2021-2026) Table 56. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2021-2026) & (US$/ton) Table 57. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2027-2032) & (k tons) Table 58. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 59. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 60. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2027-2032) Table 61. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2027-2032) & (US$/ton) Table 62. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (k tons) Table 63. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (k tons) Table 65. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (k tons) Table 67. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (k tons) Table 69. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (k tons) Table 71. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Company Information Table 73. Teva Pharmaceutical Business Overview Table 74. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 76. Teva Pharmaceutical Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 81. Sanofi Recent Development Table 82. Jhonson and Johnson Company Information Table 83. Jhonson and Johnson Business Overview Table 84. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 86. Jhonson and Johnson Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 91. Novartis Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 96. Merck Recent Development Table 97. Eli Lilly Company Information Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 101. Eli Lilly Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 106. Pfizer Recent Development Table 107. GSK Company Information Table 108. GSK Business Overview Table 109. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 111. GSK Recent Development Table 112. Bayer Company Information Table 113. Bayer Business Overview Table 114. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 115. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 116. Bayer Recent Development Table 117. Bristol-Myers Squibb Company Information Table 118. Bristol-Myers Squibb Business Overview Table 119. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 120. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 121. Bristol-Myers Squibb Recent Development Table 122. Astra Zeneca Company Information Table 123. Astra Zeneca Business Overview Table 124. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 125. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 126. Astra Zeneca Recent Development Table 127. Abbott Laboratories Company Information Table 128. Abbott Laboratories Business Overview Table 129. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 130. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio Table 131. Abbott Laboratories Recent Development Table 132. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 133. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026) & (k tons) Table 134. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2021-2026) Table 135. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032) & (k tons) Table 136. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 137. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country (2021-2026) Table 140. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Country (2027-2032) Table 142. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 143. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026) & (k tons) Table 144. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2021-2026) Table 145. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032) & (k tons) Table 146. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country (2021-2026) Table 150. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026) & (k tons) Table 154. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032) & (k tons) Table 156. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country (2021-2026) Table 160. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Country (2027-2032) Table 162. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 163. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026) & (k tons) Table 164. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2021-2026) Table 165. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032) & (k tons) Table 166. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country (2021-2026) Table 170. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026) & (k tons) Table 174. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032) & (k tons) Table 176. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country (2021-2026) Table 180. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List Table 185. Angiotensin Converting Enzyme (ACE) Inhibitors Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Image Figure 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (2021-2032) & (k tons) Figure 5. Dicarboxylate-containing Agents Image Figure 6. Global Dicarboxylate-containing Agents Sales YoY Growth (2021-2032) & (k tons) Figure 7. Sulfhydryl-containing Agents Image Figure 8. Global Sulfhydryl-containing Agents Sales YoY Growth (2021-2032) & (k tons) Figure 9. Phosphonate-containing Agents Image Figure 10. Global Phosphonate-containing Agents Sales YoY Growth (2021-2032) & (k tons) Figure 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Type 2025 VS 2032 Figure 13. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Angiotensin Converting Enzyme (ACE) Inhibitors Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cardiovascular Diseases Image Figure 26. Global Cardiovascular Diseases Sales YoY Growth (2021-2032) & (k tons) Figure 27. Kidney Diseases Image Figure 28. Global Kidney Diseases Sales YoY Growth (2021-2032) & (k tons) Figure 29. Hypertension Image Figure 30. Global Hypertension Sales YoY Growth (2021-2032) & (k tons) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k tons) Figure 33. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Application 2025 VS 2032 Figure 35. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application in 2025 Figure 45. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 62. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Angiotensin Converting Enzyme (ACE) Inhibitors Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Angiotensin Converting Enzyme (ACE) Inhibitors Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Dicarboxylate-containing Agents
  • Sulfhydryl-containing Agents
  • Phosphonate-containing Agents
Applications
  • Cardiovascular Diseases
  • Kidney Diseases
  • Hypertension
  • Other
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market by Type
  6. 1.3.1 Dicarboxylate-containing Agents
  7. 1.3.2 Sulfhydryl-containing Agents
  8. 1.3.3 Phosphonate-containing Agents
  9. 1.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type
  10. 1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Trends
  2. 2.2 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Drivers
  3. 2.3 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Angiotensin Converting Enzyme (ACE) Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Angiotensin Converting Enzyme (ACE) Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Angiotensin Converting Enzyme (ACE) Inhibitors Price (2021-2026)
  4. 3.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Angiotensin Converting Enzyme (ACE) Inhibitors Company, Product Type & Application
  7. 3.7 Global Angiotensin Converting Enzyme (ACE) Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Angiotensin Converting Enzyme (ACE) Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Angiotensin Converting Enzyme (ACE) Inhibitors Tier 1, Tier 2, and Tier 3
4 Angiotensin Converting Enzyme (ACE) Inhibitors Regional Status and Outlook
  1. 4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size by Region
  3. 4.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Angiotensin Converting Enzyme (ACE) Inhibitors by Application
  1. 5.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market by Application
  2. 5.1.1 Cardiovascular Diseases
  3. 5.1.2 Kidney Diseases
  4. 5.1.3 Hypertension
  5. 5.1.4 Other
  6. 5.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application
  7. 5.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Jhonson and Johnson
  14. 6.3.1 Jhonson and Johnson Company Information
  15. 6.3.2 Jhonson and Johnson Business Overview
  16. 6.3.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  18. 6.3.5 Jhonson and Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
  61. 6.11 Astra Zeneca
  62. 6.11.1 Astra Zeneca Company Information
  63. 6.11.2 Astra Zeneca Business Overview
  64. 6.11.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  66. 6.11.5 Astra Zeneca Recent Developments
  67. 6.12 Abbott Laboratories
  68. 6.12.1 Abbott Laboratories Company Information
  69. 6.12.2 Abbott Laboratories Business Overview
  70. 6.12.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product Portfolio
  72. 6.12.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
  2. 7.1.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
  6. 7.2.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
  2. 8.1.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
  6. 8.2.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
  2. 10.1.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
  6. 10.2.1 South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Angiotensin Converting Enzyme (ACE) Inhibitors Value Chain Analysis
  2. 12.1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Angiotensin Converting Enzyme (ACE) Inhibitors Production Mode & Process
  7. 12.2 Angiotensin Converting Enzyme (ACE) Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors Distributors
  10. 12.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst